New brain scan tracer could spot Parkinson's and related disorder

NCT ID NCT07604116

Recruiting now Diagnosis Sponsor: Synusight Biotech (Shanghai) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This early-stage study tests a new radioactive tracer called SST001 that lights up on PET scans. Researchers want to see if it is safe and can help tell the difference between multiple system atrophy (MSA) and Parkinson's disease. The study will include 30 healthy volunteers and patients with these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SST001 (a radioactive tracer for PET imaging)
What this could lead to: If successful, SST001 could become a new tool to help doctors more accurately diagnose multiple system atrophy and Parkinson's disease using brain scans.
What could go wrong: This is a very early Phase 1 study with only 30 people, focused on safety and imaging, not on treating the disease. It may not lead to a reliable diagnostic test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY (MSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple system atrophy Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SYSTEM ATROPHY (MSA) PARKINSON'S DISEASE (PD)

Contacts and locations

Locations

Affiliated Hospital of Jiangnan University
RECRUITING

Wuxi, Jiangsu, 214122, China
Huashan Hospital, Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200040, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.